• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激肽原酶、激肽形成及激肽原酶抑制在创伤后休克及相关病症中的作用。

The role of kininogenases, kinin formation and kininogenase inhibition in post traumatic shock and related conditions.

作者信息

Haberland G L

出版信息

Klin Wochenschr. 1978 Apr 1;56(7):325-31. doi: 10.1007/BF01477391.

DOI:10.1007/BF01477391
PMID:642405
Abstract

The kinin system has for a long time been considered to play a role in the pathophysiology of trauma, particularly in blood pressure changes and in inflammatory effects. Recent findings necessitate a revision of this view. It is now necessary to differentiate between two kinin systems: 1. the plasma kallikrein-HMW kininogen-kinin-system, which besides forming kinin acts decisively in Hageman Factor activation, clotting and fibrinolysis; 2. the glandular and tissue kallikrein-LMW kininogen-kinin-system which is to our present day knowledge primarily involved in kinin formation. Kinins exert a variety of actions. By interfering with angiotensin II formation, kinins may contribute to blood pressure regulation. By enhancing cellular glucose uptake and/or metabolism, they regulate partly energy production. In post traumatic states death is preceded by a severe depletion of various factors of the system and an almost total loss of kinin forming capacity. Severity and time course of these phenomena suggest that early institution of direct (Trasylol) or indirect (heparins, cortocosteroids) proteinase inhibition, and if necessary a replacement of the lost factors, should be considered.

摘要

长期以来,激肽系统一直被认为在创伤的病理生理学中发挥作用,尤其是在血压变化和炎症反应方面。最近的研究结果使这一观点有必要修正。现在有必要区分两种激肽系统:1. 血浆激肽释放酶 - 高分子量激肽原 - 激肽系统,除了形成激肽外,在激活Hageman因子、凝血和纤维蛋白溶解过程中起决定性作用;2. 腺体和组织激肽释放酶 - 低分子量激肽原 - 激肽系统,就目前所知,主要参与激肽的形成。激肽发挥多种作用。通过干扰血管紧张素II的形成,激肽可能有助于血压调节。通过增强细胞对葡萄糖的摄取和/或代谢,它们部分调节能量产生。在创伤后状态下,死亡之前会出现该系统各种因子的严重消耗以及激肽形成能力几乎完全丧失。这些现象的严重程度和时间进程表明,应考虑早期采用直接(抑肽酶)或间接(肝素、皮质类固醇)蛋白酶抑制措施,必要时补充丢失的因子。

相似文献

1
The role of kininogenases, kinin formation and kininogenase inhibition in post traumatic shock and related conditions.激肽原酶、激肽形成及激肽原酶抑制在创伤后休克及相关病症中的作用。
Klin Wochenschr. 1978 Apr 1;56(7):325-31. doi: 10.1007/BF01477391.
2
Generation, in activation and level of blood kinins during tourniquet shock in rabbits.家兔止血带休克时血液激肽的生成、失活及水平
Acta Physiol Pol. 1981 Jan-Feb;32(1):37-46.
3
[State of the kinin system in burn shock and early toxemia].[烧伤休克和早期毒血症中激肽系统的状态]
Vopr Med Khim. 1976 Sep-Oct;22(5):696-707.
4
Studies on the kinin formation by bovine spleen acid kininogenases.牛脾脏酸性激肽原酶生成激肽的研究。
Adv Exp Med Biol. 1983;156:409-18.
5
Generation of an esterolytic and kinin-forming kallikrein-alpha2-macroglobulin complex in human serum by treatment with acetone.通过丙酮处理在人血清中生成酯解和激肽形成的激肽释放酶-α2-巨球蛋白复合物。
Naunyn Schmiedebergs Arch Pharmacol. 1976 Jul;294(1):75-84. doi: 10.1007/BF00692787.
6
Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.人唾液激肽释放酶的特性:对人血浆激肽原和蛋白酶抑制剂的反应性
J Biochem. 1983 Mar;93(3):833-8. doi: 10.1093/jb/93.3.833.
7
Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein.人类高分子量(HMW)激肽原的研究。II. 人血浆激肽释放酶作用下HMW激肽原的结构变化
J Biochem. 1981 May;89(5):1465-73. doi: 10.1093/oxfordjournals.jbchem.a133339.
8
Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.血浆激肽释放酶使高分子量激肽原暴露于纤溶酶后,激肽释放增强的机制。
J Lab Clin Med. 1992 Jul;120(1):129-39.
9
Generation of kinins in synovial fluid from patients with arthropathy.关节病患者滑液中激肽的生成。
Immunopharmacology. 1997 Jun;36(2-3):209-16. doi: 10.1016/s0162-3109(97)00023-4.
10
Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis.循环及滑液中性粒细胞上的激肽释放酶、激肽原和激肽受体:在类风湿关节炎激肽生成中的作用
Rheumatology (Oxford). 2009 May;48(5):490-6. doi: 10.1093/rheumatology/kep016. Epub 2009 Mar 1.

引用本文的文献

1
Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.创伤后全身高纤溶状态:患者血浆中重叠机制的靶向蛋白质组学分析的初步研究。
J Trauma Acute Care Surg. 2018 Jun;84(6):929-938. doi: 10.1097/TA.0000000000001878.
2
The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors.激肽在血管紧张素转换酶抑制剂的降压和心脏保护作用中的角色。
Drugs. 1997;54 Suppl 5:23-30. doi: 10.2165/00003495-199700545-00005.
3
The kallikrein-kinin system in circulatory and metabolic homeostasis.

本文引用的文献

1
Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).菲茨杰拉德特质:凝血、纤维蛋白溶解、激肽生成的表面介导反应以及稀释血浆增强血管通透性(PF/Dil)的 hitherto 尚未被识别的因子、菲茨杰拉德因子的缺乏。
J Clin Invest. 1975 May;55(5):1082-9. doi: 10.1172/JCI108009.
2
Formation of bradykinin in anaphylactic and peptone shock.过敏反应和蛋白胨性休克中缓激肽的形成。
Am J Physiol. 1950 Nov;163(2):283-9. doi: 10.1152/ajplegacy.1950.163.2.283.
3
循环和代谢稳态中的激肽释放酶-激肽系统。
World J Surg. 1981 Jul;5(4):639-51. doi: 10.1007/BF01655022.
4
[New aspects of the blood flow-augmenting and insulin-like activity of muscle exercise: possible involvement of the kallikrein-kinin-prostaglandin system (author's transl)].[肌肉运动增强血流及胰岛素样活性的新方面:激肽释放酶-激肽-前列腺素系统可能的参与(作者译)]
Klin Wochenschr. 1982 May 3;60(9):429-44. doi: 10.1007/BF01720357.
5
Clinical application of inhibitors of fibrinolysis.纤维蛋白溶解抑制剂的临床应用。
Drugs. 1985 Mar;29(3):236-61. doi: 10.2165/00003495-198529030-00003.
6
The effects of the protease inhibitor, aprotinin, on the course of shock induced by endotoxin in cats.蛋白酶抑制剂抑肽酶对内毒素诱导的猫休克病程的影响。
Br J Pharmacol. 1985 Oct;86(2):399-403. doi: 10.1111/j.1476-5381.1985.tb08909.x.
[Consumption of plasma kininogens during the course of anaphylactic shock in the rabbit].
[兔过敏性休克过程中血浆激肽原的消耗]
C R Seances Soc Biol Fil. 1961;155:1411-3.
4
A micromethod for determination of bradykininogen under several conditions.一种在多种条件下测定缓激肽原的微量方法。
Ann N Y Acad Sci. 1963 Feb 4;104:77-89. doi: 10.1111/j.1749-6632.1963.tb17654.x.
5
[On plasmakinins].[关于血浆激肽]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1963;245:254-62.
6
A micromethod for the determination of bradykininogen in blood plasma.一种测定血浆中缓激肽原的微量方法。
Nature. 1961 Dec 23;192:1194-5. doi: 10.1038/1921194a0.
7
Significance of the callicreincallidinogen-callidin system in shock.
Am J Physiol. 1959 Aug;197:406-12. doi: 10.1152/ajplegacy.1959.197.2.406.
8
[The effects of trypsin inhibitors on blood coagulation].[胰蛋白酶抑制剂对血液凝固的影响]
Wien Med Wochenschr. 1960 Jul 16;110:609-12.
9
Bradykininogen and bradykinin in the cardiovascular shock produced by proteolytic enzymes.
Biochem Pharmacol. 1966 Jul;15(7):959-70. doi: 10.1016/0006-2952(66)90173-0.
10
[On the modification of postoperative blood circulation and coagulation changes with the proteinase inhibitor trasylol].[关于蛋白酶抑制剂抑肽酶对术后血液循环及凝血变化的影响]
Med Welt. 1969 May 31;22:1270-5.